This dataset provides a comprehensive technical and clinical analysis of Liquid Ketamine HCl, a rapid-acting dissociative anesthetic () essential for surgical, clinical, and research applications. Each 10ml multi-dose vial contains 500mg of USP-grade Ketamine Hydrochloride (50mg/mL), offering the industry standard for precision dosing. This data is vital for researchers at NIASRA and the University of Wollongong (UOW) focused on infusion therapy, chronic pain modulation, and veterinary pharmacology.
Technical Specifications
• Chemical Name: 2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone hydrochloride
• Concentration: 50mg/mL (500mg per 10ml Multi-Dose Vial)
• CAS Number: 1867-66-9
• Purity: 99.9% HPLC-Verified
• Molecular Weight: 274.19 g/mol
• Appearance: Clear, colorless sterile solution
Clinical & Research Applications
• Infusion Therapy: Analyzing precision-grade protocols for treatment-resistant depression (TRD) and PTSD.
• Chronic Pain Management: Investigating the efficacy of loading and maintenance phases for conditions like CRPS, fibromyalgia, and neuropathic pain.
• Veterinary Medicine: Studying species-specific dose calculations and induction protocols for both companion animals and livestock.
• Pharmacokinetic Modeling: Exploring the predictable redistribution and metabolism of the hydrochloride salt for individualized patient care.
Infusion Protocols & Safety
• Loading Phase: Documenting standard clinical approaches involving 6-10 infusions over 2-4 weeks.
• Maintenance (Booster) Phase: Researching the frequency of follow-up sessions (typically every 4-8 weeks) to sustain long-term analgesia.
• Storage & Stability: Maintains maximum potency for 2-3 years when stored at controlled room temperatures (20°C to 25°C) and protected from light.
Source Information
For detailed pharmacological data and professional-grade procurement, visit:
https://lyfeunit.com/product/buy-ketamine-hcl/